Research map: Long-term outcomes in IDH-wildtype (IDH-wt) gliomas with historical WHO grade 2 and 3 histology

Back to the article

Papers in this map

  1. Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma · Roger Stupp · 2005 · 22129 citations · Cited by this paper
  2. Contrast enhancement: the missing imaging variable in IDH-wildtype gliomas with historical WHO grade 2 and 3 histology · Alexandre Roux · 2026 · Cites this paper
  3. Long-term outcomes and late effects of surgery and radiotherapy in adult intracranial ependymoma patients · 2026 · Related
  4. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary · David N. Louis · 2021 · 12624 citations · Cited by this paper
  5. Fractionated stereotactic radiotherapy (fSRT) for symptomatic WHO grade 1 cavernous sinus meningiomas: long-term local control, clinical response, and toxicity outcomes · 2026 · Related
  6. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial · Roger Stupp · 2009 · 7879 citations · Cited by this paper
  7. Prognostic impact of concomitant leptomeningeal disease in breast cancer patients with brain metastases: a large single-center cohort study · 2026 · Related
  8. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood · Michael Weller · 2020 · 2073 citations · Cited by this paper
  9. PKA signaling modulates PRMT5/hnRNP A1-mediated IRES translation and dictates responses to mTOR inhibition in glioblastoma · 2026 · Related
  10. Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951 · Martin J. van den Bent · 2012 · 1239 citations · Cited by this paper
  11. Frameless stereotactic radiosurgery in the management of brain metastases: long-term oncologic and toxicity outcomes · 2026 · Related
  12. Sex and age interact to determine clinicopathologic differences in Alzheimer’s disease · Amanda M. Liesinger · 2018 · 132 citations · Cited by this paper
  13. Intratumoral hemorrhage in patients with brain metastasis from systemic tumors: risk factors and prognostic assessment · 2026 · Related
  14. The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study · Andres Ramos‐Fresnedo · 2022 · 78 citations · Cited by this paper
  15. Therapeutic hybrid intelligence with neural and knowledge-based expert reasoning for SRS (THINKERS): an AI model for meningioma · 2026 · Related
  16. cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics · Kenneth Aldape · 2024 · 39 citations · Cited by this paper
  17. Dual AI models for gamma knife radiosurgery in craniopharyngioma: prescription dose modeling and outcome risk prediction · 2026 · Related
  18. cIMPACT ‐ NOW update 11: Proposal on adaptation of diagnostic criteria for IDH ‐ and H3 ‐wildtype diffuse high‐grade gliomas and for posterior fossa ependymal tumors · Pieter Wesseling · 2025 · 27 citations · Cited by this paper
  19. Incidence and predictors of hemorrhage in pediatric low-grade glioma · 2026 · Related
  20. Epidemiology and survival of adult-type diffuse glioma in Belgium during the molecular era · Harry Pinson · 2023 · 21 citations · Cited by this paper
  21. Clinical characteristics, molecular reclassification trajectories and DNA methylation patterns of long- and short-term survivors of WHO grade II and III glioma · Maximilian Johannes Mair · 2025 · 4 citations · Cited by this paper
  22. Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses · Debra Nana Yeboa · 2025 · 1 citation · Cited by this paper
  23. Untitled · Cited by this paper

Source: OpenAlex (CC0)